<?xml version="1.0" encoding="UTF-8"?>
<ref id="R73">
 <label>73. •</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Dash</surname>
   <given-names>PK</given-names>
  </name>, 
  <name>
   <surname>Kaminski</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Bella</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Su</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Mathews</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Ahooyi</surname>
   <given-names>TM</given-names>
  </name>, 
  <name>
   <surname>Chen</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Mancuso</surname>
   <given-names>P</given-names>
  </name>, 
  <name>
   <surname>Sariyer</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Ferrante</surname>
   <given-names>P</given-names>
  </name>
  <etal/>: 
  <article-title>Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice</article-title>. 
  <source>Nat Commun</source>
  <year>2019</year>, 
  <volume>10</volume>:
  <fpage>2753</fpage>.
  <pub-id pub-id-type="pmid">31266936</pub-id>
 </mixed-citation>
 <note>
  <p id="P41">This report describes that sequential treatment of HIV-infected humanized mice with ‘long-acting slow-effective release’ (LASER) ART and CRISPR–Cas9 reagents caused viral clearance and prevented viral rebound in a subset of the treated animals. Transfer of splenocytes and bone marrow cells from these dual-treated virus-free animals to uninfected humanized mice failed to produce infectious progeny virus, which provided additional support for successful virus elimination.</p>
 </note>
</ref>
